Wednesday, July 24, 2013

Meeting of public laboratories

    On Wednesday 17th, a meeting of public laboratories of production of medicines took place in Santa Fe city.
    The laboratories present at this meeting were those with ANMAT *habilitation of their production areas and with national certificate of their medicines.
    Sergio Maroevich (LEM - Rosario), Juan Müller (LEM - Rosario), Patricia Rivadulla (Instituto Biológico - La Plata), Gerardo Poggioli (Instituto Biológico - La Plata), Miguel Demalde (Laboratorios Puntanos - San Luis), Daniel Salomón (LIF - Santa Fe), Roberto Ganin (LIF - Santa Fe), Carlos Arques (LIF - Santa Fe), Carlos Minatti (LIF - Santa Fe), Diego Bruno (LIF - Santa Fe) and Guillermo Cleti (LIF - Santa Fe) attended the meeting. They worked a preliminary draft about an agreement to sign in the future by these laboratories.
    The main objective will be to provide mutual assistance between the laboratories in the production of medicines.

Joint venture 

    The laboratories members decided to work together in the production of medicines for the National Program REMEDIAR. 
    Every year, REMEDIAR announces international bids to buy different medicines.
    REMEDIAR program delivers medicines to 7000 CAPS** in Argentina.

*ANMAT: Administración Nacional de Medicamentos Alimentos y Tecnología Médica. It’s the highest health authority in Argentina in control of medicines, food and medical devices.

** CAPS (Centros de Atención Primaria de la Salud) are centers of primary healthcare.

Tuesday, July 16, 2013

Lecture and Workshops at Instituto Nacional del Cáncer

    Instituto Nacional del Cáncer presented the Pilot Program for the provision of drugs to pain treatment in patients with cancer.
    LIF’s board members Carlos Arques, Diego Bruno and Guillermo Cleti participated in this meeting that took place at the headquarters of the Instituto Nacional del Cáncer.
    Also, the LIF’s staff managers who attended this meeting were Roberto Ganin, Oscar Prendes, Cecilia Selis, Roxana Mandrile, Patricia Peirotti and Silvina Mugni.
    LIF’s board member Carlos Arques gave a lecture about LIF’s history, present and future while Patricia Peirotti (LIF’s Quality Assurance Manager) delivered a presentation about Development and Research for new medicines.
    After the lectures, physicians and pharmacists from different hospitals where people under oncology therapy receive attention participated in the workshop about the provision of Metadona.
    Metadona is a drug used for the treatment of pain in oncology patients.
    Other important people who attended this meeting were Dr. Jaime Lasovski, Dr. Carlos Chiale, Dr. Jorge Zarzur, Dra. Norma Belixan, Dr. Javier Osatnik, Dra. Graciela Jacob and Dr. Roberto Wenk.

Monday, July 1, 2013

LIF: smoke free environment

    LIF has been recognized as a company with smoke free areas.
    On the World No Tobacco Day, Santa Fe Government recognized all companies which have smoke free policies.
    These activities are different Government actions to promote no smoking habits and to provide the population with information about the negative health effects of tobacco.
    LIF’s main objective is to produce medicines for the Public Health System. Also, LIF has a social responsibility with the population.
    “We have done a lot investment in machinery, equipment, staff training and building at production areas but we also want to take care of people and the environment” says Guillermo Cleti (LIF’s board member).